These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 16928872

  • 1. Endogenous cannabinoid signaling through the CB1 receptor is essential for cerebellum-dependent discrete motor learning.
    Kishimoto Y, Kano M.
    J Neurosci; 2006 Aug 23; 26(34):8829-37. PubMed ID: 16928872
    [Abstract] [Full Text] [Related]

  • 2. Central cannabinoid receptors modulate acquisition of eyeblink conditioning.
    Steinmetz AB, Freeman JH.
    Learn Mem; 2010 Nov 23; 17(11):571-6. PubMed ID: 21030483
    [Abstract] [Full Text] [Related]

  • 3. Endocannabinoid modulation of fear responses: learning and state-dependent performance effects.
    Reich CG, Mohammadi MH, Alger BE.
    J Psychopharmacol; 2008 Sep 23; 22(7):769-77. PubMed ID: 18308796
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ontogeny of delay versus trace eyeblink conditioning in the rat.
    Ivkovich D, Paczkowski CM, Stanton ME.
    Dev Psychobiol; 2000 Mar 23; 36(2):148-60. PubMed ID: 10689285
    [Abstract] [Full Text] [Related]

  • 7. Retention and extinction of delay eyeblink conditioning are modulated by central cannabinoids.
    Steinmetz AB, Freeman JH.
    Learn Mem; 2011 Oct 23; 18(10):634-8. PubMed ID: 21940395
    [Abstract] [Full Text] [Related]

  • 8. Cannabinoids modulate associative cerebellar learning via alterations in behavioral state.
    Albergaria C, Silva NT, Darmohray DM, Carey MR.
    Elife; 2020 Oct 20; 9():. PubMed ID: 33077026
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cannabinoid agonist administration within the cerebellar cortex impairs motor learning.
    Steinmetz AB, Freeman JH.
    Neurobiol Learn Mem; 2020 Apr 20; 170():106896. PubMed ID: 29964164
    [Abstract] [Full Text] [Related]

  • 11. Effects of the noncompetitive NMDA receptor antagonist MK-801 on classical eyeblink conditioning in mice.
    Takatsuki K, Kawahara S, Takehara K, Kishimoto Y, Kirino Y.
    Neuropharmacology; 2001 Oct 20; 41(5):618-28. PubMed ID: 11587717
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Classical eyeblink conditioning in glutamate receptor subunit delta 2 mutant mice is impaired in the delay paradigm but not in the trace paradigm.
    Kishimoto Y, Kawahara S, Suzuki M, Mori H, Mishina M, Kirino Y.
    Eur J Neurosci; 2001 Mar 20; 13(6):1249-53. PubMed ID: 11285022
    [Abstract] [Full Text] [Related]

  • 14. Intracerebellar cannabinoid administration impairs delay but not trace eyeblink conditioning.
    Steinmetz AB, Freeman JH.
    Behav Brain Res; 2020 Jan 27; 378():112258. PubMed ID: 31560921
    [Abstract] [Full Text] [Related]

  • 15. The endogenous cannabinoid system controls extinction of aversive memories.
    Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B.
    Nature; 2002 Aug 01; 418(6897):530-4. PubMed ID: 12152079
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice.
    Mikics E, Dombi T, Barsvári B, Varga B, Ledent C, Freund TF, Haller J.
    Behav Pharmacol; 2006 May 01; 17(3):223-30. PubMed ID: 16572000
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala.
    Kamprath K, Romo-Parra H, Häring M, Gaburro S, Doengi M, Lutz B, Pape HC.
    Neuropsychopharmacology; 2011 Feb 01; 36(3):652-63. PubMed ID: 20980994
    [Abstract] [Full Text] [Related]

  • 20. The endogenous cannabinoid system modulates nicotine reward and dependence.
    Merritt LL, Martin BR, Walters C, Lichtman AH, Damaj MI.
    J Pharmacol Exp Ther; 2008 Aug 01; 326(2):483-92. PubMed ID: 18451315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.